CMC Biologics A/S was founded in 2001 in order to provide faster and more effective solutions to the biopharmaceutical industry’s growing need for outsourced development and manufacturing resources.
To meet the needs of a growing base of customers around the world, we expanded into the U.S. through acquisition of the process development laboratories and manufacturing facility from ICOS Corporation, rebranding the global organization to CMC Biologics, Inc. in 2008. Today, our staff of more than 500 dedicated employees is committed to providing solutions for more than 100 customers on five continents.
In keeping with our focus on providing solutions to complex challenges, CMC Biologics is also committed to ecological stewardship and support of the communities in which we operate. We are ISO 14000 certified to ensure that we have processes in place to measure and improve our impact on the environment. We also provide training opportunities for university students and military service members in our local communities who are seeking to develop scientific and technical skills.
February of 2017, Asahi Glass Corporation (AGC) closed on their acquisition of CMC Biologics, establishing its location of Bothell, Washington to be their Life Science Headquarters. This acquistion aligns with AGC's goal to be the leading CDMO in the world.
Enabling our customers to treat patients with biotherapeutics.